BioPhero ApS: Financial statements 2019
CVR: 38109340
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
BioPhero ApS (CVR 38109340) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,655,278 and a net result of DKK -4,721,556 compared with DKK 0 the year before. That is an increase of 2% compared with the year before. Equity in the 2019 report amounted to DKK 10,301,150. The solvency ratio was 80%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 1,655,278
- Profit/Loss
- DKK -4,721,556
- Equity
- DKK 10,301,150
- Total Assets
- DKK 12,873,388
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.7 mio. | -4.7 mio. | 10.3 mio. | 10 |
| 2018 | - | 1.6 mio. | 0 | 3.8 mio. | 3 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of January 24, 2019, Helge Holm-Larsen has joined the board of directors of BioPhero ApS.
As of January 24, 2019, Peter Smedegaard has left the board of directors of BioPhero ApS.
About BioPhero ApS
BioPhero ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company has been dissolved on 27 October 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 28 employees (2022). In 2022, the company reported a gross profit of DKK -3,589,565 and a net result of DKK -17,401,517 compared with DKK -14,667,216 the year before. Equity in the 2022 report amounted to DKK 85,098,933.